{"transactions":[{"id":2086264,"issuer":{"id":8639,"kind":"organization","name":"ZyVersa Therapeutics, Inc."},"owners":[{"id":41698,"kind":"person","name":"O'Connor Daniel J.","position":1,"cik":"0001376847","reported_name":"O'Connor Daniel J.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}},{"id":121622,"kind":"organization","name":"Larkspur Health LLC","position":2,"cik":"0001915818","reported_name":"Larkspur Health LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Warrant (right to buy)","published_at":"2022-12-15T00:21:31.000Z","date":"2022-12-12","kind":"other","acquired":true,"shares":177204,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The Issuer completed a business combination with Larkspur Health Acquisition Corp., a Delaware corporation (\"Larkspur\") in accordance with the terms of the Business Combination Agreement, dated July 20, 2022, as amended (the \"Business Combination Agreement\") by and among ZyVersa Therapeutics, Inc., a Florida corporation (\"Old ZyVersa\"), the Securityholder Representative (as defined in the Business Combination Agreement) named therein, Larkspur, and Larkspur Merger Sub, Inc., a Delaware corporation and a direct, wholly owned subsidiary of Larkspur (\"Merger Sub\") pursuant to which Merger Sub merged with and into Old ZyVersa (the \"Acquisition Merger\"), with Old Zyversa as the surviving company of the Acquisition Merger and, after giving effecting to such Acquisition Merger, Old ZyVersa became a wholly-owned subsidiary of Larkspur and changed its name to the Issuer."},{"field":"kind","element":"transactionCoding","label":"F2","text":"The securities were previously securities of Larkspur but were converted automatically to securities of the Issuer in connection with the transactions contemplated by the Business Combination Agreement."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"The warrant is immediately exercisable in full."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"The securities are held of record by Larkspur Health LLC (the \"Sponsor\"). Daniel J. O'Connor is the sole manager of Larkspur Health LLC and in such capacity has voting and investment discretion with respect to the common stock held of record by Larkspur Health LLC. By virtue of this relationship, Mr. O'Connor may be deemed to have beneficial ownership of the securities held of record by the Sponsor. Mr. O'Connor disclaims any such beneficial ownership except to the extent of his pecuniary interest."}],"balance_after":177204,"derivative":{"exercise_price":11.5,"expiration_date":"2027-12-12","underlying":"Common Stock","underlying_shares":177204},"source":{"system":"sec-edgar","filing":"0001493152-22-035477","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1376847/000149315222035477/ownership.xml","form_type":"4"}},{"id":2086263,"issuer":{"id":8639,"kind":"organization","name":"ZyVersa Therapeutics, Inc."},"owners":[{"id":41698,"kind":"person","name":"O'Connor Daniel J.","position":1,"cik":"0001376847","reported_name":"O'Connor Daniel J.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}},{"id":121622,"kind":"organization","name":"Larkspur Health LLC","position":2,"cik":"0001915818","reported_name":"Larkspur Health LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Warrant (right to buy)","published_at":"2022-12-15T00:21:31.000Z","date":"2022-12-12","kind":"other","acquired":true,"shares":1750,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The Issuer completed a business combination with Larkspur Health Acquisition Corp., a Delaware corporation (\"Larkspur\") in accordance with the terms of the Business Combination Agreement, dated July 20, 2022, as amended (the \"Business Combination Agreement\") by and among ZyVersa Therapeutics, Inc., a Florida corporation (\"Old ZyVersa\"), the Securityholder Representative (as defined in the Business Combination Agreement) named therein, Larkspur, and Larkspur Merger Sub, Inc., a Delaware corporation and a direct, wholly owned subsidiary of Larkspur (\"Merger Sub\") pursuant to which Merger Sub merged with and into Old ZyVersa (the \"Acquisition Merger\"), with Old Zyversa as the surviving company of the Acquisition Merger and, after giving effecting to such Acquisition Merger, Old ZyVersa became a wholly-owned subsidiary of Larkspur and changed its name to the Issuer."},{"field":"kind","element":"transactionCoding","label":"F2","text":"The securities were previously securities of Larkspur but were converted automatically to securities of the Issuer in connection with the transactions contemplated by the Business Combination Agreement."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"Mr. O'Connor paid $1,000 per share of Series A Convertible Preferred Stock and warrants in an amount equal to 100% of the common shares issuable upon conversion of the Series A Convertible Preferred Stock for an aggregate of $17,500. No half shares of the Series A Convertible Preferred Stock were issued, therefore, the reporting person received 18 shares of such preferred stock instead of 17.5."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"The warrant is immediately exercisable in full."}],"balance_after":1750,"derivative":{"exercise_price":11.5,"expiration_date":"2027-12-12","underlying":"Common Stock","underlying_shares":1750},"source":{"system":"sec-edgar","filing":"0001493152-22-035477","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1376847/000149315222035477/ownership.xml","form_type":"4"}},{"id":2086262,"issuer":{"id":8639,"kind":"organization","name":"ZyVersa Therapeutics, Inc."},"owners":[{"id":41698,"kind":"person","name":"O'Connor Daniel J.","position":1,"cik":"0001376847","reported_name":"O'Connor Daniel J.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}},{"id":121622,"kind":"organization","name":"Larkspur Health LLC","position":2,"cik":"0001915818","reported_name":"Larkspur Health LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Series A Convertible Preferred Stock","published_at":"2022-12-15T00:21:31.000Z","date":"2022-12-12","kind":"other","acquired":true,"shares":1750,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The Issuer completed a business combination with Larkspur Health Acquisition Corp., a Delaware corporation (\"Larkspur\") in accordance with the terms of the Business Combination Agreement, dated July 20, 2022, as amended (the \"Business Combination Agreement\") by and among ZyVersa Therapeutics, Inc., a Florida corporation (\"Old ZyVersa\"), the Securityholder Representative (as defined in the Business Combination Agreement) named therein, Larkspur, and Larkspur Merger Sub, Inc., a Delaware corporation and a direct, wholly owned subsidiary of Larkspur (\"Merger Sub\") pursuant to which Merger Sub merged with and into Old ZyVersa (the \"Acquisition Merger\"), with Old Zyversa as the surviving company of the Acquisition Merger and, after giving effecting to such Acquisition Merger, Old ZyVersa became a wholly-owned subsidiary of Larkspur and changed its name to the Issuer."},{"field":"kind","element":"transactionCoding","label":"F2","text":"The securities were previously securities of Larkspur but were converted automatically to securities of the Issuer in connection with the transactions contemplated by the Business Combination Agreement."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"Mr. O'Connor paid $1,000 per share of Series A Convertible Preferred Stock and warrants in an amount equal to 100% of the common shares issuable upon conversion of the Series A Convertible Preferred Stock for an aggregate of $17,500. No half shares of the Series A Convertible Preferred Stock were issued, therefore, the reporting person received 18 shares of such preferred stock instead of 17.5."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"The Series A Convertible Preferred Stock is perpetual and therefore has no expiration date."}],"balance_after":1750,"derivative":{"exercise_price":10,"exercise_date":"2022-12-12","underlying":"Common Stock","underlying_shares":1750},"source":{"system":"sec-edgar","filing":"0001493152-22-035477","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1376847/000149315222035477/ownership.xml","form_type":"4"}},{"id":2086261,"issuer":{"id":8639,"kind":"organization","name":"ZyVersa Therapeutics, Inc."},"owners":[{"id":41698,"kind":"person","name":"O'Connor Daniel J.","position":1,"cik":"0001376847","reported_name":"O'Connor Daniel J.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}},{"id":121622,"kind":"organization","name":"Larkspur Health LLC","position":2,"cik":"0001915818","reported_name":"Larkspur Health LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2022-12-15T00:21:31.000Z","date":"2022-12-12","kind":"other","acquired":true,"shares":1377598,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The Issuer completed a business combination with Larkspur Health Acquisition Corp., a Delaware corporation (\"Larkspur\") in accordance with the terms of the Business Combination Agreement, dated July 20, 2022, as amended (the \"Business Combination Agreement\") by and among ZyVersa Therapeutics, Inc., a Florida corporation (\"Old ZyVersa\"), the Securityholder Representative (as defined in the Business Combination Agreement) named therein, Larkspur, and Larkspur Merger Sub, Inc., a Delaware corporation and a direct, wholly owned subsidiary of Larkspur (\"Merger Sub\") pursuant to which Merger Sub merged with and into Old ZyVersa (the \"Acquisition Merger\"), with Old Zyversa as the surviving company of the Acquisition Merger and, after giving effecting to such Acquisition Merger, Old ZyVersa became a wholly-owned subsidiary of Larkspur and changed its name to the Issuer."},{"field":"kind","element":"transactionCoding","label":"F2","text":"The securities were previously securities of Larkspur but were converted automatically to securities of the Issuer in connection with the transactions contemplated by the Business Combination Agreement."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"The securities are held of record by Larkspur Health LLC (the \"Sponsor\"). Daniel J. O'Connor is the sole manager of Larkspur Health LLC and in such capacity has voting and investment discretion with respect to the common stock held of record by Larkspur Health LLC. By virtue of this relationship, Mr. O'Connor may be deemed to have beneficial ownership of the securities held of record by the Sponsor. Mr. O'Connor disclaims any such beneficial ownership except to the extent of his pecuniary interest."}],"balance_after":1377598,"source":{"system":"sec-edgar","filing":"0001493152-22-035477","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1376847/000149315222035477/ownership.xml","form_type":"4"}},{"id":2339118,"issuer":{"id":8639,"kind":"organization","name":"ZyVersa Therapeutics, Inc."},"owners":[{"id":121622,"kind":"organization","name":"Larkspur Health LLC","position":1,"cik":"0001915818","reported_name":"Larkspur Health LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Class B Common Stock","published_at":"2022-03-10T22:32:48.000Z","date":"2022-01-06","kind":"other","acquired":true,"shares":3427,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"As described in the issuer's registration statement on Form S-1 (File No. 333-256056) (the \"Registration Statement\") under the section entitled \"Description of Securities - Founder Shares,\" the shares of Class B Common Stock, par value $0.0001 per share, will automatically be converted into shares of Class A Common Stock, par value $0.0001 per share, at the time of the issuer's initial business combination, on a one-for-one basis, subject to certain adjustment described therein, and have no expiration date"},{"field":"kind","element":"transactionCoding","label":"F3","text":"In connection with the partial exercise of the underwriters' over-allotment option, A.G.P./Alliance Global Partners transferred 3,427 shares to the reporting person for no consideration."},{"field":"shares","element":"transactionShares","label":"F3","text":"In connection with the partial exercise of the underwriters' over-allotment option, A.G.P./Alliance Global Partners transferred 3,427 shares to the reporting person for no consideration."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"As described in the issuer's registration statement on Form S-1 (File No. 333-256056) (the \"Registration Statement\") under the section entitled \"Description of Securities - Founder Shares,\" the shares of Class B Common Stock, par value $0.0001 per share, will automatically be converted into shares of Class A Common Stock, par value $0.0001 per share, at the time of the issuer's initial business combination, on a one-for-one basis, subject to certain adjustment described therein, and have no expiration date"},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"As described in the issuer's registration statement on Form S-1 (File No. 333-256056) (the \"Registration Statement\") under the section entitled \"Description of Securities - Founder Shares,\" the shares of Class B Common Stock, par value $0.0001 per share, will automatically be converted into shares of Class A Common Stock, par value $0.0001 per share, at the time of the issuer's initial business combination, on a one-for-one basis, subject to certain adjustment described therein, and have no expiration date"}],"balance_after":1141326,"derivative":{"underlying":"Class A Common Stock","underlying_shares":3427},"source":{"system":"sec-edgar","filing":"0001213900-22-011646","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1859007/000121390022011646/ownership.xml","form_type":"4"}},{"id":2339117,"issuer":{"id":8639,"kind":"organization","name":"ZyVersa Therapeutics, Inc."},"owners":[{"id":121622,"kind":"organization","name":"Larkspur Health LLC","position":1,"cik":"0001915818","reported_name":"Larkspur Health LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Class A Common Stock","published_at":"2022-03-10T22:32:48.000Z","date":"2022-01-06","kind":"other","acquired":true,"shares":236273,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These shares are underlying units (each unit consisting of one share of Class A common stock and three-fourths of one warrant, each whole warrant exercisable to purchase one share of Class A common stock) acquired in a private placement by the Reporting Person in connection with the issuer's initial public offering and subsequent partial exercise of the underwriters' over-allotment option. The above refers to the shares of Class A common stock included in the units purchased."}],"balance_after":236273,"source":{"system":"sec-edgar","filing":"0001213900-22-011646","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1859007/000121390022011646/ownership.xml","form_type":"4"}}]}